School of Medicine


Showing 101-120 of 122 Results

  • Arthur Sung, MD, FCCP

    Arthur Sung, MD, FCCP

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Sung is a highly esteemed, fellowship-trained interventional pulmonologist and a fellow of the American College of Chest Physicians.

    He is the senior associate chief of the Stanford Medicine Division of Pulmonary, Allergy and Critical Care Medicine. He founded the interventional pulmonology and bronchoscopy for Stanford Medicine in 2013. With Stanford University School of Medicine, he is a clinical associate professor of medicine – pulmonary, allergy and critical care medicine.

    In his clinical practice, Dr. Sung delivers care at Stanford Medicine sites in both Palo Alto, Emeryville and Livermore. He is a recognized expert in the diagnosis and treatment of conditions involving the chest and lungs, including complex airway diseases.

    Patients praise the quality of his care and excellent listening skills. They highlight his ability to answer questions and to explain medical conditions and treatment options clearly and compassionately.

    To advance the field of pulmonology, Dr. Sung is conducting research in airways diseases. He is a principal investigator of a study of variables in computed tomography imaging used to support diagnostic and treatment approaches. He previously served as the site principal investigator for lung volume reduction procedure for COPD.

    Dr. Sung has co-authored articles published in the Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Thoracic Imaging, Chest, and elsewhere. Topics have included innovations in therapy for pneumonitis and robotic surgical treatment of lung tumors.

    He has written chapters for books such as Principles and Practice of Interventional Pulmonology, Examination of the Larynx through the Bronchoscope, and Airway Anatomy for the Bronchoscopist.

    Dr. Sung has made presentations to the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. Topics have included lung cancer staging in the era of personalized medicine.

    Dr. Sung has earned recognition from the College of Chest Physicians. The Stanford Leadership Program has recognized his achievements. From the Stanford University Bio-X program, he received a grant to study ultrasound-guided lung biopsy procedures. The Bio-X program fosters interdisciplinary collaboration among biomedical and life science researchers, clinicians, engineers, physicists, and computational scientists.

    He is a member of the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. He has volunteered his time and expertise to deliver health care services to those in need. New Orleans Mayor Ray Nagins honored Dr. Sung for providing care to victims of Hurricane Katrina.

  • Andrew Sweatt

    Andrew Sweatt

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.

  • Jyothi Tirumalasetty, MD, FAAAAI, FACAAI

    Jyothi Tirumalasetty, MD, FAAAAI, FACAAI

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Tirumalasetty is a board-certified, fellowship-trained allergist and immunologist in the Stanford Health Care Allergy, Asthma, and Immunodeficiency Clinic. She is also a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine. Dr. Tirumalasetty completed fellowship training in allergy and immunology from the Northwestern University Feinberg School of Medicine in Chicago, IL.

    She specializes in diagnosing and treating asthma and food and drug allergies in adults. Her clinical focus areas also include chronic cough, immunotherapy to prevent allergies, and biologics to treat asthma. Biologics are used to prevent airway inflammation and other asthma symptoms. Dr. Tirumalasetty works closely with her patients to provide a comprehensive evaluation and an innovative, patient-centered care plan.

    Dr. Tirumalasetty has been co-investigator in multiple clinical trials funded by the National Institutes of Health (NIH). Her research interests include studying health inequity in food allergy, sustainability in medicine, and severe allergic asthma. Dr. Tirumalasetty is the primary investigator on a research project supported by Stanford Medicine’s Spectrum Pilot Grant. She is collaborating with a multidisciplinary team of physicians within Stanford. The Green Inhaler Pilot Project focuses on educating Stanford Health Care providers and encouraging them to prescribe inhalers that emit lower levels of greenhouse gases.

    Dr. Tirumalasetty has presented to her colleagues at lectures all over the nation. Her presentations have covered a range of topics, including atopy in asthma, managing food and drug allergies, and anaphylaxis (severe allergic reaction). Dr. Tirumalasetty has been interviewed as an allergy expert for several articles in national publications, including The New York Times. She serves as a medical advisor on the board of directors for Securing Safe Food, a nonprofit organization that works with food pantries to provide allergen-free food to people with food allergies.

    Dr. Tirumalasetty’s articles have appeared in numerous peer-reviewed journals, including The Journal of Allergy and Clinical Immunology, Journal of Asthma, Expert Review of Clinical Immunology, and Annual Review of Immunology. She published a book chapter about immunotherapy for food allergies in Reference Module in Food Science. She has served as an ad hoc peer reviewer for Clinical and Translational Allergy, Allergy Journal, and World Allergy Organization Journal.

    Dr. Tirumalasetty is a fellow of the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology. She is a member of several professional organizations, including the European Academy of Allergy & Clinical Immunology; World Allergy Organization; Western Society of Allergy, Asthma & Immunology; American Thoracic Society; and California Society of Allergy, Asthma and Immunology.

  • Helena Turton

    Helena Turton

    Postdoctoral Scholar, Pulmonary and Critical Care Medicine

    BioHelena is a Postdoctoral Research Scholar in Professor Edda Spiekerkoetter's laboratory in the School of Medicine. Her main focus is investigating right ventricular adaption and maladaptation in response to an increased afterload. She is also interested in left and right ventricular interdependence in pulmonary arterial hypertension (PAH) . Helena completed her PhD in Pulmonary Vascular Biology under the supervision of Dr Roger Thompson, Professor Allan Lawrie, and Professor Sheila Francis at the University of Sheffield, UK. Her research focus also includes the investigation of dsRNA signalling in pulmonary vascular remodelling in PAH and pulmonary veno-occlusive disease (PVOD).

  • Ann Weinacker

    Ann Weinacker

    Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.

  • Jennifer Williams

    Jennifer Williams

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Williams is a fellowship-trained pulmonologist specializing in pulmonary critical care medicine. She has board certification in pulmonary medicine, critical care medicine, and internal medicine.

    She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.

    For each patient, Dr. Williams develops a comprehensive and compassionate care plan. Her goal is to help every individual achieve the best possible lung health and quality of life.

    Patient reviews praise the quality of the care she delivers, her thoroughness, and her patient skills.

    Dr. Williams has participated in clinical research studies. She has published articles on autoimmune disease involving interstitial lung disease, COPD, and life-threatening pulmonary complications associated with leukemia. She also co-authored an article on the development of guidelines for identifying and managing post-traumatic stress disorder symptoms associated with critical illness.

    Her work has appeared in peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Internal Medicine, and elsewhere. She also has written chapters in books on critical care medicine and clinical decision-making.

    Dr. Williams speaks English and both written and oral medical Spanish. In her free time, she enjoys soccer and distance running.

  • Timothy Ting-Hsuan Wu

    Timothy Ting-Hsuan Wu

    MD Student, expected graduation Spring 2024
    Ph.D. Student in Biochemistry, admitted Summer 2021
    MSTP Student
    Casual - Non-Exempt, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsMolecular and cellular basis of lung development, renewal and disease;
    Single cell analysis of SARS-CoV-2 lung infection;
    Vascular inflammation and immune dysregulation in pulmonary hypertension.

  • Roham Zamanian

    Roham Zamanian

    Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.

    2. Prevalence and Treatment of Insulin Resistance in PAH.

    3. Role of inflammation and proteomic signature in PAH

    4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.

    5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension

    6. Assessment of microvascular function in PAH.